Arnaud Lavergne

8PUBLICATIONS
78CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersMolecular targetsInnate immunityDevelopmental genetics (incl. sex determination)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 08, 2025
Targeting myoferlin in ER/Golgi vesicle trafficking reprograms pancreatic cancer-associated fibroblasts.

Raphaël Peiffer, Emilie Laverdeur, Anthoula Gaigneaux

|Jul 15, 2025
Subversion of mRNA degradation pathways by EWSR1::FLI1 represents a therapeutic vulnerability in Ewing sarcoma.

Bartimée Galvan, Loïc Ongena, Jonathan Bruyr

|Feb 07, 2025
IL-4 induces CD22 expression to restrain the effector program of virtual memory T cells.

Bin Yang, Ophélie Piedfort, Guillem Sanchez-Sanchez

|Jul 31, 2024
Loss of Elp3 blocks intestinal tuft cell differentiation via an mTORC1-Atf4 axis.

Caroline Wathieu, Arnaud Lavergne, Xinyi Xu

|Jun 07, 2024
Valine aminoacyl-tRNA synthetase promotes therapy resistance in melanoma.

Najla El-Hachem, Marine Leclercq, Miguel Susaeta Ruiz

Pageof 2